Abstract

Cells resistant to pyrazofurin and 6-azauridine have been selected from a simian virus 40-transformed Syrian hamster line and from a Chinese hamster lung line. By increasing the concentrations of inhibitors in several steps, mutant cells from both lines have been obtained which resist high concentrations (1 to 5 mM) of the two inhibitors separately or together. Orotidine-5'-phosphate decarboxylase (EC 4.1.1.23), the sixth and last enzyme in UMP biosynthesis, is inhibited by the nucleoside monophosphates derived from pyrazofurin or 6-azauridine. The activity of this enzyme is increased in each resistant cell line tested. Furthermore, there is a parallel increase in each case in the activity of the fifth enzyme of the pathway, orotate phosphoribosyltransferase (EC 2.4.2.10), which is not inhibited by pyrazofurin or 6-azauridine monophosphates, and the amount of increase is up to 67 times the level found in wild type cells. In contrast, the activities of the first three enzymes of UMP biosynthesis remain essentially unchanged in the mutants. Resistant Chinese hamster cells remain sensitive to 5-fluorouridine; this indicates that uridine kinase, the enzyme necessary to convert 6-azauridine to the monophosphate, is still functional.

Highlights

  • Cells resistant to pyrazofurin and 6-azauridine have been selected from a simian virus 40-transformed Syrian hamster line and from a Chinese hamster lung line

  • Orotidine-5’phosphate decarboxylase (EC 4.1.1.23), the sixth and last enzyme in UMP biosynthesis, is inhibited by the nucleoside monophosphates derived from pyrazofurln or 6-azauridlne

  • We show that cells selected for resistance to these two inhibitors separately or together overproduce coordinately both orotate phosphoribosyltransferase and orotidine-Y-phosphate decarboxylase, the two enzymes of Complex U

Read more

Summary

Coordinate Overproduction of Orotate

Phosphoribosyltransferase in Hamster Cells Resistant and to (Received for publication, October 10, 1978, and in revised form, December 11, 1978). Orotidine-5’phosphate decarboxylase (EC 4.1.1.23), the sixth and last enzyme in UMP biosynthesis, is inhibited by the nucleoside monophosphates derived from pyrazofurln or 6-azauridlne. The activity of this enzyme is increased in each resistant cell line tested. Complex A includes the first three enzymes of the pathway (carbamyl-P synthetase, aspartate transcarbamylase and dihydroorotase) and Complex LJ includes the last two enzymes (orotate phosphoribosyltransferase and orotidine-5’-phosphate decarboxylase). ’ The abbreviations used are: PALA, N-(phosphonacetyl)+-aspartate; CAD, the multifunctional polypeptide which comprises carbamyl-P synthetase, aspartate transcarbamylase, and dihydroorotase; pyrazofurin, 3,P-n-ribofuranosyl-4-hydroxypyrazole-5-carboxamide; PRPP, 5-phosphoribosyl-l-pyrophosphate; CHL, Chinese hamster lung. We show that cells selected for resistance to these two inhibitors separately or together overproduce coordinately both orotate phosphoribosyltransferase and orotidine-Y-phosphate decarboxylase, the two enzymes of Complex U

PROCEDURES
RESULTS
Transferase activity’
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call